The endothelin system. A new target for therapeutic intervention.

Since its identification in 1988,1 endothelin has attracted intensive interdisciplinary research interest because of its unique profile as an endothelium-derived vasoactive factor with a powerful and characteristically long-lasting vasopressor activity. Indeed, in terms of cellular mechanisms of action, endothelin appears to be quite similar to many classic vasoconstrictor substances such as angiotensin II and norepinephrine. However, the slow time course of the regulatory mechanisms of its biosynthesis and secretion more resembles that of inflammatory cytokines, giving this family of small peptides a unique position within the realm of intercellular mediators with cardiovascular relevance.

[1]  L. V. von Segesser,et al.  Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. , 1994, Circulation.

[2]  W. Hubbard,et al.  Endothelin receptor subtypes in human and guinea‐pig pulmonary tissues , 1993, British journal of pharmacology.

[3]  T. Godfraind.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery , 1993, British journal of pharmacology.

[4]  W. Neidhart,et al.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist , 1993, Nature.

[5]  J. Vane,et al.  Use of the endothelin antagonists BQ‐123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF , 1993, British journal of pharmacology.

[6]  M. Yano,et al.  A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. , 1993, Biochemical and biophysical research communications.

[7]  A. Doherty,et al.  Structure-activity relationships of C-terminal endothelin hexapeptide antagonists. , 1993, Journal of medicinal chemistry.

[8]  G. Grover,et al.  The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. , 1993, Cardiovascular research.

[9]  G. Remuzzi,et al.  A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. , 1993, Kidney international.

[10]  R. N. Garrison,et al.  Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. , 1993, Surgery.

[11]  A. Davenport,et al.  Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. , 1993, Kidney international.

[12]  J. Gratton,et al.  Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney. , 1993, European journal of pharmacology.

[13]  D. Webb,et al.  Endothelin: progress in pharmacology and physiology. , 1993, Trends in pharmacological sciences.

[14]  S. Douglas,et al.  Endothelin‐1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ‐123 , 1993, British journal of pharmacology.

[15]  T. Inagami,et al.  Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. , 1992, Kidney international.

[16]  J. R. Wu-wong,et al.  Endothelin‐converting enzymes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  T. Watanabe,et al.  Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. , 1991, Circulation research.

[18]  K. Badr,et al.  Biological actions and pathophysiologic significance of endothelin in the kidney. , 1991, Kidney international.

[19]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[20]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[21]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[22]  大中 佳三.  Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium , 1995 .

[23]  P. Siegl,et al.  Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. , 1994, Kidney International.

[24]  V. Breu,et al.  Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. , 1994, Circulation research.

[25]  D. Rigel,et al.  Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. , 1993, Journal of cardiovascular pharmacology.

[26]  S. Douglas,et al.  Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats. , 1993, Journal of cardiovascular pharmacology.

[27]  M. Yano,et al.  Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. , 1993, Life sciences.

[28]  D. Pollock,et al.  Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. , 1993, The American journal of physiology.

[29]  R. Leduc,et al.  Presence of furin mRNA in cultured bovine endothelial cells and possible involvement of furin in the processing of the endothelin precursor. , 1993, Journal of cardiovascular pharmacology.

[30]  T. Watanabe,et al.  Role of endogenous endothelin in extension of rabbit myocardial infarction. , 1993, Journal of cardiovascular pharmacology.

[31]  R. Miller,et al.  The structure and specificity of endothelin receptors: their importance in physiology and medicine. , 1993, Pharmacology & therapeutics.

[32]  C. Thiemermann,et al.  Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065. , 1993, Journal of cardiovascular pharmacology.

[33]  M. J. Sumner,et al.  Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction. , 1993, Journal of cardiovascular pharmacology.

[34]  S. Ozaki,et al.  A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors. , 1992, Life sciences.

[35]  H. Matsumoto,et al.  Pathophysiological role of endothelin in acute renal failure. , 1990, Life sciences.

[36]  M. Yanagisawa,et al.  Molecular biology and biochemistry of the endothelins. , 1989, Trends in pharmacological sciences.